Devil and the Deep Blue Sea?

Scientists instinctively love nanotechnology, which is why they shouldn't be in charge of it.

Written byGlenn McGee
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Just because I am an ethicist does not mean I am opposed to making money, particularly when it comes with solid scientific discoveries that benefit human kind. The field of nanotechnology carries that promise. Unfortunately, many ecorestoration, environmentalist, or "green movement" corporations are more concerned with greener wallets than a greener world.

Planktos is a for-profit ecorestoration company, based in San Francisco, which aims to restore damaged habitats. Its plan is to release "forest-sized areas" of nano-sized particles of zero-valent iron (ZVI) into the ocean, with the hope that plankton will take up that iron, engage in enhanced photosynthesis, consume greater quantities of carbon dioxide from the environment, and curb global warming.

Planktos is not the only group seeking to capitalize upon the convergence of the green movement. Green building, using the advances of nanotechnology, could make our houses better insulated, more brightly lit with less energy, more efficient in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies